<DOC>
	<DOCNO>NCT02988362</DOCNO>
	<brief_summary>The purpose study compare safety pharmacokinetics HL068 ( Candesartan 16 mg Amlodipine 10mg ) coadministration two separate drug healthy male volunteer .</brief_summary>
	<brief_title>Bioequivalence Study ( Candesartan 16 mg Amlodipine 10 mg )</brief_title>
	<detailed_description />
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Healthy male volunteer age 19 55 year old . Body mass index ( BMI ) range 18.5 27.0 kg/m2 Understand requirement study voluntarily consent participate study . Previous history present clinically significant digestive , cardiovascular , respiratory , psychiatric , endocrine , hepatobiliary , renal disease . History gastrointestinal disease gastrointestinal surgery affect drug absorption . Subjects hereditary problem , example , galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption . Subjects whose clinical laboratory test value outside accept normal range . Especially , ASTor ALT &gt; 1.5 time Upper Normal Limit total bilirubin &gt; 1.5 time Upper Normal Limit Positive test result Hepatitis B antibody , Hepatitis C virus antibody , Syphilis regain test Participation clinical investigation within 3 month prior study drug administration Subjects whole blood donation within 60 day component blood donation within 30days blood transfusion within 30days prior first dosing . SBP ≥ 140 mmHg &lt; 115 mmHg , DBP ≥ 90 mmHg &lt; 70 mmHg Caffeine &gt; 400mg/day Alcohol &gt; 30g/day Cigarette &gt; 10 cigarettes/day . Subjects judge unsuitable investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>